FitLife Brands, Inc. (FTLF) stock
FTLFNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 4/3016% above fair value
$8.30−0.02 (-0.24%)
Close on Nov 12, 2026Market cap $77.95MP/E 43.7Yield –
FitLife Brands EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
FitLife Brands's EV/EBITDA was 17.6× on Nov 11, 2026, against 16.5× a year earlier. Over the last 5 years it ranged from 5.5× to 47.2×, with a median of 13.8×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 17.6× | +2.8 |
| 2025 | Dec 31, 2025 | 14.8× | +2.1 |
| 2024 | Dec 31, 2024 | 12.7× | −0.8 |
| 2023 | Dec 29, 2023 | 13.6× | +4.7 |
| 2022 | Dec 30, 2022 | 8.8× | −1.3 |
| 2021 | Dec 31, 2021 | 10.2× | +4.0 |
| 2020 | Dec 31, 2020 | 6.2× | +0.5 |
| 2019 | Dec 31, 2019 | 5.7× | +1.4 |
| 2017 | Apr 28, 2017 | 4.3× | +2.8 |
| 2016 | Feb 29, 2016 | 1.5× | +1.3 |
| 2015 | Jan 30, 2015 | 0.2× | −0.1 |
| 2014 | Dec 31, 2014 | 0.3× | −6.7 |
| 2013 | Oct 31, 2013 | 6.9× | +1.8 |
| 2012 | Dec 31, 2012 | 5.1× | – |
See a number that looks wrong?